2022 annual financial data
Xilio Therapeutics 2022 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -89,149,000 USD and net income was -87,295,000 USD.
Operating cash flow was -75,723,000 USD.
Get free Xilio Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -89,149,000 USD
- Net income
- -87,295,000 USD
- Operating cash flow
- -75,723,000 USD